TACE Plus HAIC With Oxaliplatin and Raltitrexed for BCLC Stage C HCC
Clinical trial NCT04597970 · UNKNOWN
Trial details
- NCT number
- NCT04597970
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-20
- Primary completion
- 2021-10-20
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.